Technical Analysis for NTUS - Natus Medical Incorporated

Grade Last Price % Change Price Change
grade B 30.2 -0.49% -0.15
NTUS closed down 0.49 percent on Wednesday, August 21, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical NTUS trend table...

Date Alert Name Type % Chg
Multiple of Ten Bullish Other 0.00%
Fell Below 20 DMA Bearish -0.49%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.20%
NR7 Range Contraction -2.20%
Inside Day Range Contraction -2.20%
Overbought Stochastic Strength -2.20%
MACD Bearish Signal Line Cross Bearish -0.23%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.23%
Multiple of Ten Bullish Other -0.23%
Wide Bands Range Expansion -0.23%

Older signals for NTUS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers. Additionally, it offers jaundice management products; brain injury products; NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Pleasanton, California.
Medicine Health Medical Specialties Diseases Disorders Nursing Epilepsy Infancy Sleep Disorders Intensive Care Medicine Software Systems Hearing Loss Streaming Video Audiology Neonatal Intensive Care Unit Neonatology
Is NTUS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 37.45
52 Week Low 22.25
Average Volume 206,633
200-Day Moving Average 28.7992
50-Day Moving Average 27.48
20-Day Moving Average 30.6945
10-Day Moving Average 31.148
Average True Range 1.1803
ADX 18.13
+DI 16.3136
-DI 26.7447
Chandelier Exit (Long, 3 ATRs ) 29.3091
Chandelier Exit (Short, 3 ATRs ) 25.7909
Upper Bollinger Band 33.8574
Lower Bollinger Band 27.5316
Percent B (%b) 0.42
BandWidth 20.608904
MACD Line 0.9332
MACD Signal Line 1.2435
MACD Histogram -0.3103
Fundamentals Value
Market Cap 981.23 Million
Num Shares 32.5 Million
EPS 0.58
Price-to-Earnings (P/E) Ratio 52.07
Price-to-Sales 2.93
Price-to-Book 3.06
PEG Ratio 1.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.39
Resistance 3 (R3) 31.37 30.97 31.19
Resistance 2 (R2) 30.97 30.66 30.97 31.12
Resistance 1 (R1) 30.58 30.48 30.38 30.60 31.06
Pivot Point 30.18 30.18 30.08 30.18 30.18
Support 1 (S1) 29.79 29.87 29.59 29.81 29.34
Support 2 (S2) 29.39 29.69 29.39 29.28
Support 3 (S3) 29.00 29.39 29.21
Support 4 (S4) 29.02